Aims Metabolic remodelling in cardiac hypertrophy is underscored by a reduction in fatty acid (FA) oxidation. We tested whether this decline in FA oxidation in the presence of enhanced FA supply may predispose the hypertrophied myocardium to lipid accumulation, functional deterioration, and eventually heart failure. Methods and results Left ventricular hypertrophy was induced surgically in Sprague-Dawley rats by inter-renal aortic constriction. Rats were fed a Western diet (WD, 45% kcal from lipids) or standard diet (SD, 12% kcal from fat) for 9 weeks post-surgery. Hearts were perfused in the isovolumic mode with a physiological mixture of substrates including 5 mM 1-13 C glucose, 1 mM 3-13 C lactate, and 0.3 mM U-13 C palmitate, and cardiac function was monitored. Real-time PCR was used to determine transcript levels of peroxisome proliferator-activated receptor-a (PPARa) and PPARa-regulated metabolic enzymes. Palmitate oxidation and PPARa-regulated gene expression were markedly reduced in the hypertrophied myocardium of rats fed SD. However, 9 weeks of WD normalized both palmitate oxidation and PPARa-regulated gene expression but significantly increased glucose and lactate oxidation in the hypertrophied hearts. This was accompanied by cardiac triglyceride accumulation and a decline in ventricular function despite an increase in oxygen consumption. Conclusion These results highlight that WD-induced dysregulation of FA metabolism has deleterious functional consequences in cardiac hypertrophy.
Introduction
Obesity is a growing threat to global health by virtue of its association with a number of cardiovascular risk factors including insulin resistance, hypertension, and dyslipidaemia-collectively referred to as 'metabolic syndrome'. 1 The incidence of cardiovascular events related to obesity, primarily ischaemic heart disease, has risen to epidemic levels in the western world, 2 as has the prevalence of 'obesity cardiomyopathy', i.e. myocardial dysfunction in obese individuals which is unrelated to coronary artery disease, hypertension, or diabetes. 3, 4 Indeed, obesity is an independent risk factor for myocardial dysfunction and heart failure (HF). 4 Yet, the cellular mechanisms that precede contractile dysfunction in obesity cardiomyopathy are incompletely understood.
Left ventricular hypertrophy (LVH, secondary to hypertension) often observed in obesity 4, 5 is another independent risk factor for HF. A shift in myocardial substrate oxidation from fatty acids (FA) towards carbohydrates is a key feature of hypertrophic remodelling. [6] [7] [8] Although initially beneficial, a sustained decline in FA oxidation (in the face of unaltered FA uptake) may cause an inappropriate accumulation of lipids in the hypertrophied myocardium resulting in contractile dysfunction, cell death, and eventually HF 9 -highlighting the potential role of metabolic remodelling in the transition to HF.
The concurrent occurrence of obesity and LVH has been associated with contractile dysfunction 5 ultimately leading to HF. 4 However, the mechanistic links between obesity, LVH, and non-ischaemic HF are incompletely understood. In a number of pathophysiological states, there is evidence to support that a mismatch between myocardial uptake and oxidation of FA may lead to abnormally high intracellular triglyceride levels and contractile dysfunction: from patients with inherited defects in mitochondrial long-chain acyl-CoA dehydrogenase (a key enzyme of FA oxidation pathway) 10 and mice with cardiac-specific over-expression of peroxisome proliferator-activated receptor-a (PPARa) 11 and acyl-CoA synthase 12 to rodent models of obesity and diabetes. 3, 13 Moreover, intramyocardial lipid deposits have † Present address. Department of Cardiology, King's College, London
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been observed in obese patients with non-ischaemic HF. 3 In light of these studies, it is feasible that obesity when co-existent with LVH may enhance FA supply to the myocardium (already confronting reduced FA oxidation due to pressure-overload) leading to dysregulation of FA metabolism, lipid accumulation, and ultimately HF. Consequently, elucidating the profile of substrate utilization in the hypertrophied myocardium in the setting of obesity is vital to define the mechanisms underlying the transition to HF.
Furthermore, cardiac lipid accretion and contractile dysfunction is associated with altered expression of metabolic genes including activation of myocardial PPARa and PPARa-regulated genes [muscle-type carnitine palmitoyl transferase-1 (mCPT1), medium-chain acyl-CoA dehydrogenase (MCAD), and pyruvate dehydrogenase kinase-4 (PDK4)] in both clinical and experimental obesity 3, 11 together with down-regulation of insulin-sensitive glucose transporter (GLUT4) and phosphofructokinase genes. 11 However, little is known regarding the combined effects of obesity and pressure-overload on myocardial metabolic gene expression.
To date, the link between perturbed FA homeostasis and myocardial dysfunction has largely been investigated in genetic models of obesity, 3, [11] [12] [13] where rodents become obese when fed a low-fat diet. In contrast, excess dietary fat (providing 40% of the overall energy) appears to play a crucial role in human obesity.
14 Yet, little is known about myocardial function and substrate oxidation in diet-induced obesity.
The aim of this study, therefore, was to determine the impact of Western diet (WD, 45% kcal from lipids) on myocardial function, substrate oxidation, and metabolic gene expression in pressure-overload hypertrophy. Our findings demonstrate that 9 weeks of WD give rise to a type-2 diabeteslike phenotype (obesity, hyperglycaemia, and hyperlipidaemia) in the setting of LVH and adversely affect cellular remodelling in the hypertrophied myocardium, characterized by normalization of palmitate oxidation and PPARa-regulated gene expression. This is accompanied by myocardial triglyceride accumulation and a marked decline in contractile efficiency-highlighting that WD-induced alterations in FA metabolism are detrimental in LVH.
Methods

Surgery and dietary manipulation
This investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No.85-23, revised 1996) and the UK Animals (Scientific Procedures) Act 1986 and approved by the University of Hull Ethical Review Process. LVH was induced surgically in male SpragueDawley rats (220-250 g, Charles River Inc., Kent, UK), by abdominal aortic-constriction (AC) as described previously 7, 15 following anaesthesia with isoflurane in oxygen (3% in 3 L/min). Control animals (Con) underwent the same procedure but without constriction of the aorta. Rats were assigned to either a WD (824053, Special Diets Services, UK) or standard rodent diet (SD, BK001E, B&K Universal Ltd, UK) for 9 weeks post-surgery and maintained in a 12:12 h light/dark cycle, thereby giving rise to four experimental groups: (i) control rats fed SD (Con þ SD), (ii) rats with AC fed SD (AC þ SD), (iii) control rats fed WD (Con þ WD), and (iv) rats with AC fed WD (AC þ WD). Results from rats fed SD have been published previously. 7 The source and calorie composition of the diets is given in Table 1 . The fat in WD was derived from lard. Body weights were recorded weekly. The degree of hypertrophy was evaluated by determining the heart weight-to-tibia length ratio at the end of 9 weeks.
In vitro cardiac function
Hearts were isolated and perfused at a constant coronary flow rate (14 mL/min) in a modified isovolumic Langendorff mode as previously described 7, 16 with Krebs-Henseleit bicarbonate buffer containing 3% bovine serum albumin (essentially FA free, Serologicals, USA), 5 mM glucose, 1 mM sodium lactate, 0.1 mM sodium pyruvate, 0.3 mM sodium palmitate, 0.5 mM glutamine, and insulin (0.1 mU/ mL). Cardiac function [i.e. left ventricular developed pressure (LVDP) and heart rate (HR)] was monitored continuously and myocardial oxygen consumption (MVO 2 ) determined as described previously in detail. 7, 16 Rate pressure product (RPP ¼ LVDP Â HR) was calculated and the RPP/ MVO 2 ratio used as an indicator of cardiac efficiency.
Myocardial substrate oxidation
After a 20 min equilibration, the perfusion medium was switched to an identical buffer but containing palmitate labelled uniformly with 13 C (U-13 C palmitate) and either 3-13 C lactate or 1-13 C glucose and perfused for an additional 45 min. Hearts were freeze-clamped with Wollenberger tongs at the end of the experiment. Frozen hearts were powdered, extracted in 6% perchloric acid as previously described 17 and reconstituted in deuterated phosphate buffer (pH 6.8). 13 C NMR (nuclear magnetic resonance) spectra of cardiac extracts were acquired as described previously 7 and the relative contributions of 13 C labelled palmitate, lactate, and glucose to the total acetyl-CoA pool entering the TCA 13 C-glutamate spectra as detailed previously. 18 The contribution of unlabelled substrates to the total acetyl-CoA pool was calculated as described previously. 16 Subsequently, the absolute oxidation rate of the labelled substrates was determined (using the relative contributions of the substrates and MVO 2 ) as described by Lloyd et al.
19,20
Tissue triglyceride measurements
In a separate series of experiments, ventricular tissue from all four groups (Con þ SD, AC þ SD, Con þ WD, and AC þ WD) was rapidly removed, freeze-clamped, and lipids extracted by a modified method of Bligh and Dyer. 21 Myocardial triglyceride content was assayed using a Sigma kit (TR0100).
Serum analysis
Blood was collected from terminally anaesthetized rats (following intraperitoneal injection of sodium thiopentone 100 mg/kg body weight) and centrifuged (3000 rpm, 10 min, 48C) to obtain serum. Concentrations of triglyceride and free fatty acids (FFA) were measured using kits from Sigma (TR0100) and Roche (1-383-175), respectively, while that of glucose was determined spectrophotometrically. 22 Haematocrit was measured using an ABL-77 series blood-gas analyser (Radiometer, Copenhagen, Denmark). Serum insulin and leptin levels were quantified using ELISA assay kits from Mercodia w (10-1137-01) and US Biological (L1670-30J), respectively, according to manufacturer's instructions.
mRNA measurements
RNA extraction and real-time PCR were performed on frozen ventricular tissue using previously described methods. 7, 23 Primers sequences for the rat cardiac-specific genesCalsequestrin-2 (CSQ2), PPARa, mCPT1, MCAD, PDK isoforms 2 and 4, GLUT4, fatty acid translocase (CD36), and mitochondrial uncoupling proteins (UCP) 2 and 3-have been published previously 7 as have the optimal conditions for real-time PCR. Briefly, 2 mg of total RNA was reversetranscribed into first-strand cDNA. 7 Subsequently, transcript expression was quantified (in triplicate) by real-time PCR using Bio-Rad iCycler w IQ detection system. The reaction mixture contained cDNA (1 mL), forward and reverse primers (1.5 mL each, 75 nM final concentration), 10 mL of 2Â ABsolute SYBR green fluorescein master mix (ABgene, AB-1219/A) containing Taq polymerase, and 6 mL of RNAsefree water. The correlation between the number of PCR cycles required for fluorescent signal to reach the threshold (Ct) and the amount of standard was linear over a 5-log range of RNA for all assays. Ct values for all transcripts were normalized to that of housekeeping gene CSQ2 and changes in transcript expression between different groups calculated using modified DDCt method. 24 Finally, transcript expression in each group was expressed as fold change compared with Con þ SD.
Western blot analysis
Protein extracts from ventricular tissue were prepared as described previously. 15 Samples containing 50 mg protein were separated on a 10% SDS-polyacrylamide gel, transferred to nitrocellulose membrane and probed with antibodies specific to CD36 as described previously in detail 7, 25 and proteins visualized using ECL light detection kit (Amersham).
Enzyme assay
Myocardial MCAD activity was measured in powdered ventricular tissue by following the decrease in ferricinium ion absorbance as described by Lehman et al. 26 
Statistical analysis
Data are expressed as mean + SEM. Single comparison of means was performed by an independent two-tailed t-test, while multiple comparisons were carried out with analysis of variance (ANOVA) followed by Scheffé test for post hoc analysis using SPSS statistical software (v. 15). A value of P , 0.05 was considered significant.
Results
Morphology of aortic-constriction and dietary fat supplementation
Nine weeks post-surgery, a marked increase in heart weight (22-33%) and heart weight-to-tibia length ratio (19-36%)-both indices of LVH-was observed in rats subjected to AC, irrespective of dietary manipulation ( Table 2) . WD did not markedly increase heart weight in control rats suggesting that the hypertrophy observed in AC þ WD was primarily due to pressure-overload. At the time of sacrifice, both Con þ WD and AC þ WD showed signs of obesity with markedly higher body weights ( Table 2 ) and abdomino-thoracic fat deposits (data not shown) compared with their respective counterparts fed SD. 7 Although rats fed WD had 19% lower voluntary food ingestion than those on SD, the kilocalories intake was approximately the same in the two groups [86.3 + 4.1 kcal/day, WD vs. 77.6 + 5.0 kcal/day, SD] since the energy density of WD (4.54 kcal/g) was higher than that of SD (3.3 kcal/g). Tibia length was unaltered by AC or dietary manipulation. Neither AC þ SD nor AC þ WD had any overt signs of HF (oedema, breathlessness, and fatigue), anaemia (Haematocrit), or fluid retention in the lungs (% H 2 O) ( Table 2) . Fluid/water retention in the lungs was determined as described previously. 7 
Serum metabolite and hormone levels
Serum levels of glucose in the SD groups are summarized in Table 3 and are consistent with previously published data on Sprague-Dawley rats 7, 27 (and supplier's datasheets www.criver.com). Serum glucose was substantially elevated (19-22%) in the WD group vs. SD group (Table 3) , as were serum triglyceride (31-57%), FFA (47-76%), and leptin (P , 0.01) levels. However, serum insulin levels were unchanged following AC or dietary manipulation ( Table 3 ).
Cardiac triglyceride concentrations
Myocardial triglyceride content was significantly higher in WD group compared with their respective counterparts fed SD ( Table 3 ), indicating that WD promotes myocardial lipid accumulation.
In vitro cardiac function
Cardiac function, MVO 2 , and efficiency, averaged over 45 min of perfusion with 13 C-enriched substrates are given in Table 4 . Myocardial function as determined by RPP was preserved in AC þ SD (vs. Con þ SD) indicating that the hypertrophy was compensatory.
7 Following 9 weeks of WD, ventricular function declined in both Con þ WD (28%) and AC þ WD (34%) primarily as a result of lowered heart rate. MVO 2 increased (70-85%) in the WD group (vs. respective counterparts fed SD) with a consequent decline in cardiac efficiency. The fall in efficiency was pronounced (P , 0.05) in AC þ WD vs. Con þ WD, highlighting the exaggerated effect of WD on cardiac hypertrophy.
Myocardial substrate oxidation
The absolute oxidation rates of 13 C labelled palmitate, lactate, and glucose are shown in Figure 1 . Myocardial palmitate oxidation was significantly reduced in AC þ SD vs. Con þ SD while that of lactate and glucose was unaltered. 7 Thus, the discrepancy in myocardial substrate provision in AC þ SD was made up through an increased oxidation of unlabelled substrates (exogenous pyruvate and endogenous triglycerides).
Following 9 weeks of WD, palmitate oxidation was unaltered in Con þ WD (vs. Con þ SD) but normalized in AC þ WD (i.e. returned to the level in Con þ SD; 35 + 4.2 nmol/ min/g wet wt; Figure 1) . However, myocardial oxidation of lactate and glucose were markedly elevated (P , 0.05) in the WD group (421 + 38 and 89 + 7.8 AC þ WD; 361 + 41 and 89 + 7.6 Con þ WD; n ¼ 4, nmol/min/g wet wt) vs. SD group, highlighting increased reliance of the myocardium on exogenous carbohydrates even in the presence of surplus circulating lipids. Consequently, the contribution of unlabelled substrates was minimal. Results expressed as mean + SEM. Con þ SD, control rats fed standard diet; AC þ SD, aortic-constricted rats fed standard diet; Con þ WD, control rats fed western diet; AC þ WD, aorticconstricted rats fed western diet; TG, triglycerides, FFA, free fatty acids, n, number of animals. *P , 0.05 vs. Con þ SD, † P , 0.05 vs. AC þ SD. Results expressed as mean + SEM. Con þ SD, control rats fed standard diet; AC þ SD, aortic-constricted rats fed standard diet; Con þ WD, control rats fed western diet; AC þ WD, aorticconstricted rats fed western diet; HR, heart rate; LVDP, left ventricular developed pressure; RPP, rate pressure product; MVO 2 , myocardial oxygen consumption; CE, cardiac efficiency; bpm, beats per minute; n, number of animals.
*P , 0.05 vs. Con þ SD, #P , 0.05 vs. Con þ WD; † P , 0.05 vs. AC þ SD. Results expressed as mean + SEM. Con þ SD, control rats fed standard diet; AC þ SD, aortic-constricted rats fed standard diet; Con þ WD, control rats fed western diet; AC þ WD, aorticconstricted rats fed western diet; HW, heart weight; BW, body weight; TL, tibia length; n, number of animals. *P , 0.05 vs. Con þ SD, † P , 0.05 vs. AC þ SD, #P , 0.05 vs. Con þ WD.
Metabolic gene expression
The mRNA transcript levels of the key metabolic enzymes are shown in Table 5 . Expression of myocardial PPARa and PPARa-regulated genes, namely mCPT1, MCAD, UCP3, and PDK4 was significantly down-regulated in AC þ SD compared with Con þ SD 7 , highlighting expression of the hypertrophic phenotype. In addition, there was a marked reduction in PDK2 transcript levels. UCP2 expression was substantially higher in AC þ SD vs. Con þ SD. However, no changes in the mRNA levels of CD36 and GLUT4 were observed.
Following 9 weeks of WD, cardiac expression of PPARa, mCPT1, MCAD, UCP3, and PDK 2 and 4 was unaltered in Con þ WD (vs. Con þ SD) but normalized in AC þ WD, indicating reversal of transcript expression and consistent with the recovery/normalization of myocardial palmitate oxidation. UCP2 mRNA levels were substantially reduced in Con þ WD but elevated in AC þ WD. Further, CD36 transcript expression was markedly higher while that of GLUT4 was appreciably lower in both Con þ WD and AC þ WD.
Expression of CD36
Ventricular CD36 protein levels were markedly elevated in both Con þ WD and AC þ WD compared with Con þ SD and AC þ SD, respectively (Figure 2 ).
Medium-chain acyl-CoA dehydrogenase activity
Myocardial MCAD activity, a marker of mitochondrial b-oxidative capacity was significantly higher (P , 0.01) in WD group (8.9 + 0.4 Con þ WD, 8.5 + 0.3 AC þ WD; n ¼ 6, mmol/min/g wet heart weight) compared with SD group (6.4 + 0.3 Con þ SD, 5.2 + 0.1 AC þ SD; n ¼ 4, mmol/min/ g wet heart weight), thus explaining, in part, the recovery of myocardial palmitate oxidation in AC þ WD.
Discussion
The present study demonstrates for the first time that WD reverses/normalizes myocardial palmitate oxidation and PPARa-regulated gene expression in pressure-overload hypertrophy without affecting the hypertrophic response. This is accompanied by cardiac triglyceride accumulation and an exaggerated decline in contractile efficiency, indicating that WD-induced dysregulation of FA metabolism has deleterious functional consequences in LVH. Further, 9 weeks of WD reduces ventricular function and gives rise to a type-2 diabetes-like phenotype (obesity, hyperglycaemia, and dyslipidaemia) in both control and aortic-constricted animals, highlighting the onset of cardio-metabolic syndrome. Figure 1 Absolute oxidation rates of exogenous palmitate, lactate and glucose in Con þ SD (open bars, control rats fed Standard diet), AC þ SD (black bars, aortic-constricted rats fed standard diet), Con þ WD (grey bars, control rats fed Western diet) and AC þ WD (grey hatched bars, aorticconstricted rats fed Western diet) groups. Results expressed as mean + SEM. n, number of animals; *P , 0.05 vs. Con þ SD, † P , 0.05 vs. AC þ SD. Table 5 Relative transcript expression of cardiac metabolic genes mRNA expression for each gene was determined by real-time PCR and normalized to that of calsequestrin (CSQ2) before being expressed as fold change in each group vs. Con þ SD. Results presented as mean + SEM.
Con þ SD, control rats fed standard diet; AC þ SD, aortic-constricted rats fed standard diet; Con þ WD, control rats fed western diet; AC þ WD, aorticconstricted rats fed western diet; PPARa, peroxisome proliferated-activator receptor a; mCPT1, muscle carnitine palmitoyl transferase1; Pyruvate dehydrogenase kinase (PDK) isoforms 2 and 4; mitochondrial uncoupling proteins (UCPs) 2 and 3; MCAD, medium-chain acyl-CoA dehydrogenase; CD36, fatty acid translocase; GLUT 4, insulin-sensitive glucose transporter. P , 0.05 vs. Con þ SD; n, number of animals; NS, not significant. Figure 2 Western blot for CD36 from representative gel of a Con þ SD (control rats fed standard diet), AC þ SD (aortic-constricted rats fed standard diet), Con þ WD (control rats fed Western diet) and AC þ WD (aorticconstricted rats fed Western diet) rat ventricular tissue run in duplicate. n, number of animals.
Cardiac hypertrophy
Irrespective of the dietary manipulation, abdominal AC generated a moderate degree of cardiac hypertrophy ( Table 2 ) comparable to that observed previously 7, 15 with no evidence of HF. Further, unchanged heart weight in Con þ WD is consistent with a recent study 28 and suggests that the continuing hypertrophy observed in AC þ WD is primarily due to pressure-overload.
Diet-induced phenotype
Despite consuming equivalent kilocalories, rats fed WD had 12-18% greater weight gain than those fed SD, primarily due to fat deposition. Enhanced body weight in the WD group is in agreement with the earlier studies 14, 29 as are elevated serum glucose, 14, 30 triglyceride, 31 FFA, 28 and leptin 29 levels ( Table 3) . While hyperlipidaemia may be a direct consequence of dietary fat supplementation, hyperglycaemia could be attributed to diminished GLUT4 protein levels and/or defective insulin signalling in the skeletal muscles (from chronic exposure to high serum lipids) that limit glucose uptake. 32 Hyperleptinaemia failed to curb the weight gain and/or calorie consumption indicating the development of leptin resistance. 1, 29 Together, these findings highlight the onset of a type-2 diabetes-like phenotype (obesity, hyperglycaemia, and dyslipidaemia) in the WD group.
Myocardial substrate metabolism
In the present study, myocardial palmitate oxidation was unchanged in Con þ WD vs. Con þ SD (Figure 1) . Altered substrate availability is unlikely to limit FA oxidation, since the perfusate contained 0.3 mM palmitate-a level similar to that of serum FFA ( Table 3) . A decline in FA uptake can be ruled out since there was an up-regulation of cardiac CD36 (mRNA and protein, Figure 2 ) levels together with elevation of cardiac triglyceride concentration. These findings suggest that the myocardium had reached its maximum capacity for palmitate oxidation and that surplus FA were being stored as triglycerides or diverted to other deleterious pathways. 1 In contrast, in a recent study, oleate oxidation was markedly enhanced with a consequent suppression of glucose oxidation in Wistar rats fed WD for 8 weeks. 28 In the hypertrophied myocardium, however, palmitate oxidation normalized (but not increased) after 9 weeks of WD. This could be attributed to elevated serum lipids (Table 3 ) and the resultant re-induction of myocardial FA oxidation genes through activation of PPARa regulatory system. 33 This view is further strengthened by the observed increase in MCAD activity in AC þ WD. Nevertheless, the substantially higher oxidation of glucose and lactate in the WD group in the presence of high circulating lipids highlights the simplicity and efficiency of carbohydrate oxidation 6 in the functionally compromised hearts.
Hearts were perfused in the isovolumic mode here as opposed to working mode in the previous study. 28 Cardiac work is considerably higher in the working mode than in the isovolumic mode. Since work performed is a key determinant of energy substrate use, 8 the differences in metabolic profile can be attributed to higher workload of the ejecting heart used. 28 Preference was given to a noncirculating isovolumic mode here in order to avoid ambiguity arising from the re-entry of 13 C label into the system and avert functional deterioration from toxic metabolites. 34 Disparity in metabolic profile seen here can also arise from the use of a more physiological mixture of substrates including lactate and pyruvate as alternative carbohydrate sources, while the previous study employed solely glucose (11 mM) and oleate (0.4 mM) as substrates. 28 
Pathophysiology of pressure-overload and Western diet
Heart rate was substantially reduced while LVDP was modestly (10-15%) lower in rats fed WD than those on SD ( Table 4 ). Desensitization of b 1 -adrenoceptors and/or disruption of downstream b-adrenoceptor signalling from exposure to high circulating lipids and consequent reduction in cardiac sympathetic tone may, in part, explain the observed decline in heart rate 35 in the WD group. Consequently, cardiac function as determined by RPP was markedly lower in the WD group. Nevertheless, no significant difference in function was observed between Con þ WD and AC þ WD. Poor cardiac performance in rats fed WD may arise from a number of reasons including, spatial hindrance of the contractile machinery by triglyceride accumulation (making it difficult to sustain contractions with appropriate amplitude in cardiomyocytes), 1 myocardial energy deficiency arising from the uncoupling of mitochondrial oxidative phosphorylation (mOxPhos) and futile metabolic loop (that cycles FA in and out of the triglyceride pool in the presence of high intracellular FA), 30 and cardiotoxicity from lipid accumulation. 12, 13 Consistent with our present study, Dahl salt-sensitive rats fed WD with high salt also exhibited reduced cardiac function. 36 In contrast, cardiac power was unaltered in Wistar rats fed WD for 8 weeks 28 despite myocardial triglyceride accumulation. These discrepancies could be attributed to the differences in experimental models, dietary FA composition, and methods used to assess cardiac function (in vivo or in vitro). Nevertheless, the findings in this study together with others emphasize that cardiac lipid accumulation may be one factor contributing to functional deterioration.
Obesity-induced increase in cardiac preload, FA metabolism, and reactive oxygen species generation may enhance MVO 2 37 -factors which may underlie elevated MVO 2 in the present study. Indeed, MVO 2 was appreciably higher in AC þ WD (70% vs. AC þ SD and 12% vs. Con þ WD) and consequently, cardiac efficiency considerably lower, suggesting that cardiac work was done at a greater cost of oxygen in the hypertrophied hearts confronting surplus lipids.
The decline in cardiac efficiency observed here can be considered a reflection of enhanced MVO 2 . Increased energy utilization for excitation-contraction (EC) coupling and elevated basal metabolism could lead to heightened MVO 2 . 38 Basal metabolism is unlikely to be altered since hearts were perfused at a constant flow rate. However, high extra-cellular calcium concentration has been shown to augment MVO 2 by increasing energy utilization associated with EC coupling 39 and abnormal calcium homeostasis has been observed in cardiomyocytes exposed to long-chain FA 40 -a factor which may underlie the observed increase in MVO 2 here. Alternatively, surplus FA in the cellular milieu could uncouple mOxPhos and enhance MVO 2 . 41 Finally, high levels of intracellular FA could hasten oxygen wasting by triggering oxygen-dependent cycling of FA into triglycerides and vice versa. 30, 38 Despite a reduction in function and efficiency, AC þ WD did not go into failure but may succumb to additional mechanical/metabolic stress.
Metabolic gene expression
In parallel with the changes in myocardial palmitate oxidation, real-time PCR analysis revealed that expression of PPARa, mCPT1, and MCAD was unaltered in Con þ WD but normalized in AC þ WD ( Table 5 ). In agreement with this, cardiac PPARa and mCPT1 expression were unchanged in Wistar rats fed WD for 8 weeks 28 and in Wistar-Kyoto rats subjected to left coronary artery ligation and fed WD for 12 weeks. 33 Re-induction of PPARa and its target genes in AC þ WD could be attributed, in part, to the activation of PPARa regulatory system by elevated serum lipids. 33 Further, enhanced CD36 transcript and protein expression in the WD group suggests elevated FA import. Indirect support for this comes from elevated myocardial triglyceride content in rats fed WD. Hyperlipidiaemia 42 and hyperglycaemia (via PPARg) 43 have been shown to up-regulate myocardial CD36 mRNA levels-both of which may account for the observed increase in CD36 transcripts here.
The role of UCPs in the heart is still unclear. It has been proposed that UCP3 may regulate cardiac FA utilization and ATP synthesis 44 and that elevated UCP3 levels may be detrimental to the metabolically stressed hypertrophied heart. 45 Normalization of UCP3 expression in parallel with myocardial palmitate oxidation and a substantial decline in ventricular function in AC þ WD supports this view. In addition, reversal of UCP3 together with PPARa expression suggests that transcription of this protein is regulated by PPARa. 45, 46 FA-induced up-regulation of UCP2 levels and consequent uncoupling of mOxPhos may account, in part, for the higher MVO 2 and lower cardiac efficiency in AC þ WD vs. Con þ WD. 41, 46 The expression profile of PDK4 is largely unknown in the metabolically stressed hypertrophied heart. Myocardial carbohydrate (glucose þ lactate) oxidation increased substantially in AC þ WD despite normalization of PDK4 mRNA expression. Consequently, alterations in PDK4 expression alone cannot explain changes in carbohydrate oxidation. Nevertheless, normalization of PDK4 together with PPARa expression reiterates that this transcript is PPARa regulated. 47 Repression of GLUT4 transcript levels in the both Con þ WD and AC þ WD could be attributed to enhanced FA oxidation, 48 and/or inhibition by elevated FA levels either directly or via involvement of a number of transcription factors. 49 Enhanced mitochondrial FA oxidation can lead to a state of ATP oversupply, which would enhance cellular ATP/AMP ratio and inactivate AMPK (adenosine monophosphate-activated protein kinase). 48 This, in turn, may inactivate transcription factor MEF2A (myocyte enhancer factor-2A) and its coactivator, PGC-1a (PPARg coactivator-1a), leading to diminished GLUT4 gene expression. 50, 51 In conclusion, the present study has shown that WD impairs cellular remodelling in compensated cardiac hypertrophy characterized by the normalization of myocardial palmitate oxidation and PPARa-regulated gene expression. This is accompanied by enhanced carbohydrate oxidation, cardiac lipid accumulation, and an exaggerated decline in contractile efficiency. Whether these adaptations hasten the transition into HF when the efficiency-compromised hypertrophied hearts encounter additional mechanical or metabolic stress warrants further investigation.
